The global Lennox-Gastaut syndrome therapeutics market is experiencing a period of significant expansion. This phenomenon can be credited to several factors, including an growing prevalence of Lennox-Gastaut syndrome globally and progresses in treatment strategies. The market is fueled by a growing requirement for effective therapies to treat the c